Examkin

Soru

Zorluk: OrtaGastroenterology and Hepatology

A 52-year-old woman is evaluated in the emergency department for an 8-hour history of severe, steady right upper quadrant abdominal pain that radiates to her back, accompanied by nausea. Her temperature is 37.2°C (99.0°F), blood pressure is 130/80 mm Hg, and pulse is 88/min. Physical examination shows scleral icterus and right upper quadrant tenderness without guarding or rebound. Laboratory studies show:

- Leukocyte count: 8,500/mm38,500/\text{mm}^3
- Total bilirubin: 2.4 mg/dL2.4 \text{ mg/dL}
- Alkaline phosphatase: 260 U/L260 \text{ U/L}
- Aspartate aminotransferase (AST): 115 U/L115 \text{ U/L}
- Alanine aminotransferase (ALT): 120 U/L120 \text{ U/L}
- Lipase: 40 U/L40 \text{ U/L}

Arrange the following clinical interventions in the most appropriate chronological sequence for the complete evaluation and management of this patient, starting from her immediate arrival. Assume that any diagnostic imaging performed reveals findings consistent with an intermediate probability for choledocholithiasis (e.g., a dilated common bile duct without a definitively visualized ductal stone).

  1. 1Administer intravenous fluids and analgesia
  2. 2Perform right upper quadrant transabdominal ultrasound
  3. 3Obtain magnetic resonance cholangiopancreatography (MRCP)
  4. 4Perform endoscopic retrograde cholangiopancreatography (ERCP)
  5. 5Perform laparoscopic cholecystectomy

Cevap

The correct sequence is: 1) Administer intravenous fluids and analgesia, 2) Perform right upper quadrant transabdominal ultrasound, 3) Obtain magnetic resonance cholangiopancreatography (MRCP), 4) Perform endoscopic retrograde cholangiopancreatography (ERCP), 5) Perform laparoscopic cholecystectomy.
The correct sequence for managing intermediate-risk choledocholithiasis begins with patient stabilization using intravenous fluids and analgesia. A right upper quadrant ultrasound is the initial imaging test of choice for suspected biliary pathology. If the ultrasound confirms a dilated duct but no visible stone in a patient with abnormal liver enzymes (indicating an intermediate probability for choledocholithiasis), an MRCP or endoscopic ultrasound is required to non-invasively confirm the diagnosis. Once the stone is confirmed, ERCP is indicated for therapeutic extraction. Finally, laparoscopic cholecystectomy is performed prior to hospital discharge to prevent recurrent biliary complications.

Adım Adım Çözüm

1
Recognize the need for initial clinical stabilization.
The patient receives intravenous fluids and analgesia.
Supportive care is paramount in managing acute abdominal pain before proceeding with diagnostic testing.
2
Select the best initial imaging modality for suspected biliary pathology.
A transabdominal ultrasound is performed.
Ultrasound is the most cost-effective and non-invasive initial test to visualize gallstones and ductal dilation.
3
Risk-stratify for choledocholithiasis based on clinical, laboratory, and initial ultrasound findings.
The patient is identified as intermediate risk, prompting an MRCP.
Intermediate risk (abnormal LFTs, dilated duct, no cholangitis) requires non-invasive confirmation before subjecting the patient to the risks of ERCP.
4
Provide therapeutic intervention for the confirmed common bile duct stone.
An ERCP is performed.
ERCP allows for direct intervention, such as sphincterotomy and stone extraction.
5
Determine the definitive surgical management plan.
Laparoscopic cholecystectomy is performed.
Removing the gallbladder during the same admission prevents future gallstone-related complications.

Anahtar Kavram

The management of intermediate-risk suspected choledocholithiasis involves initial stabilization, right upper quadrant ultrasound, non-invasive ductal imaging (MRCP or EUS) for confirmation, therapeutic ERCP for stone extraction, and definitive laparoscopic cholecystectomy.
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Gastroenterology and Hepatology

Bu konudan daha fazla soru